Dako, Genentech to Seek FDA OK on HER-2 Companion Tests for Herceptin in Gastric Cancer

Dako's HER-2 tests may be used as companion diagnostics for Herceptin in treating stomach cancer.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.